Press release
Preclinical Oncology Models Market Companies Study -Aragen Bioscience, vivoPharm Pty. Ltd. Bioduro, Crown Bioscience Inc., Charles River
Preclinical Oncology Models Market
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on "Global Preclinical Oncology Models Market- By Product Type (Patient-Derived Xenograft Models (PDX), Cell Line Derived Xenograft Models, Syngeneic Models, Genetically engineered mouse models (GEMMs), Orthotopic Models, Custom Xenograft and Syngeneic Model) - Global Forecast to 2030" The report features detailed industry analysis and extensive insights on the market, exploring its significant growth factors.
Get Free Access to Demo Report, Excel Pivot and ToC : www.insightaceanalytic.com/request-sample/1093
The global preclinical oncology models market was estimated to be worth US$ 1,020.2 million in 2021 and is projected to grow to US$ 2,463.7 million in 2030, with a promising compound annual growth rate (CAGR) of 10.6% from 2022 to 2030, according to the most recent market intelligence research report by InsightAce Analytic.
Preclinical oncology models are necessary for scientists to forecast the clinical effectiveness of new anticancer drugs. Preclinical models are therefore crucial for accurately screening anticancer drugs with strong clinical connection.Numerous preclinical and translational issues have arisen as a result of the rising need for cancer immunotherapy. models are therefore crucial for accurately screening anticancer drugs with strong clinical connection.
The market is anticipated to grow during the forecast period due to a number of factors, including improvements in immuno-oncology, a rise in targeted and novel cancer therapies, an increasein oncology and drug development research and development activities, a high demand for reliable preclinical oncology models, such as humanized and syngeneic tumor models, and the growing need to lower translational failures in clinical trials. In In addition, the market for preclinical oncology models is growing due to the early detection of predictive biomarkers and the necessity of logical combination therapy design.
Preview for Detailed TOC: https://www.insightaceanalytic.com/report/global-preclinical-oncology-models-market/1093
Expert Knowledge, Just a Click Away:https://calendly.com/insightaceanalytic/30min?month=2024-02
The prominent players in the preclinical oncology models industry include:
Aragen Bioscience, vivoPharm Pty. Ltd. Bioduro, Crown Bioscience Inc., Charles River, Champion Oncology, Inc., Envigo, GenOway S.A., Hera BioLabs, MI Bioresearch Inc, Pharmatest Services, Taconic Biosciences, Inc., The Jackson Laboratory, and Other Prominent Players.
Key Industry Developments from Leading Players:
• In Dec 2021, Crown Bioscience, a leading contract research organization (CRO) in preclinical and translational drug development services, expanded its Crown Bioscience United Kingdom facility. This expansion offers additional imaging modalities to visualize better and understand tumor progression and response to potential therapies. The additional imaging platform allows performing cutting-edge preclinical studies, offering advanced insights on potential drug candidates before clinical trials.
• In Feb 2021, Charles River Laboratories International, Inc. partnered with Kibur Medical to provide exclusive access to its implantable microdevice (IMD) for in vivo preclinical oncology studies.
• In May 2020, BioDuro, LLC, a leading drug discovery and development services organization, announced the availability of two new preclinical models for Non-alcoholic steatohepatitis (NASH) that highly resemble the clinical progression of the disease. The models include mouse and hamster species and manifest all the hallmarks of NASH disease, enabling drug developers to evaluate broad classes of drug targets, including metabolic inflammation and fibrogenic pathways alike.
Preclinical Oncology Models Market Regional Analysis:
Due to the increased demand for cancer immunotherapies, rising oncology research funding, and the requirement for preclinical oncology models, North America is anticipated to be the most profitable area of this market over the forecast years.
During the predicted period, the Asia Pacific region is expected to grow. The factors driving the regional market expansion include the increased demand for targeted medicines, the technical advancements in cancer diagnosis and treatment methods, andthe growing R&D efforts in oncology clinical trials by industry players.
Unlock Your GTM Strategy:www.insightaceanalytic.com/customisation/1093
The Preclinical Oncology Models Market Segments
The Preclinical Oncology Models Market Estimates (Value US$ Million) & Forecasts and Trend Analyses, 2019 to 2030 based on Product
• Patient-Derived Xenograft Models (PDX)
• Cell Line Derived Xenograft Models
• Syngeneic Models
• Genetically engineered mouse models (GEMMs)
• Orthotopic Models
• Custom Xenograft and Syngeneic Model
• Others
The Preclinical Oncology Models Market Estimates (Value US$ Million) & Forecasts and Trend Analyses, 2019 to 2030 based on Application
• Neuroblastoma
• Prostate Cancer
• Pancreatic Cancer
• Breast Cancer
• Colorectal Cancer
• Bladder Cancer
• Fibrosarcoma
• Kidney Cancer
• Liver Cancer
• Lung Cancer
• Lymphoma
• Skin Cancer
• Others
The Preclinical Oncology Models Market Estimates (Value US$ Million) & Forecasts and Trend Analyses, 2019 to 2030 based on Region
• Europe
• North America
• Latin America
• Asia Pacific
• Middle East & Africa
North America Preclinical Oncology Models Market Estimates Revenue (US$ Million) by Country, 2019 to 2030
• U.S.
• Canada
Europe Preclinical Oncology Models Market Estimates Revenue (US$ Million) by Country, 2019 to 2030
• Germany
• France
• Italy
• Spain
• Russia
• Rest of Europe
Asia Pacific Preclinical Oncology Models Market Estimates Revenue (US$ Million) by Country, 2019 to 2030
• India
• China
• Japan
• South Korea
• Australia & New Zealand
Latin America Preclinical Oncology Models Market Estimates Revenue (US$ Million) by Country, 2019 to 2030
• Brazil
• Mexico
• Rest of Latin America
The Middle East & Africa Preclinical Oncology Models Market Estimates Revenue (US$ Million) by Country, 2019 to 2030
• GCC Countries
• South Africa
• Rest of the Middle East & Africa
Empower Your Decision-Making with 180 Pages Full Report @www.insightaceanalytic.com/buy-report/1093
About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.
Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 551 226 6109
Asia: +91 79 72967118
info@insightaceanalytic.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Preclinical Oncology Models Market Companies Study -Aragen Bioscience, vivoPharm Pty. Ltd. Bioduro, Crown Bioscience Inc., Charles River here
News-ID: 3795589 • Views: …
More Releases from InsightAce Analytic Pvt. Ltd.
Organic Feminine Care Market to Benefit from Increasing Government Initiatives a …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Organic Feminine Care Market Size, Share & Trends Analysis Report By Product Type (Sanitary Pads, Tampons, Menstrual Cups, Liners and Shields, Others), by Nature (Disposable, Reusable), by Age Group (Upto 18 Years, 19-30 Years, 31-40 Years, 41 Years and Above), by Distribution Channel (Supermarkets and hypermarkets, Pharmacy, Online Stores, Others)- Market Outlook And Industry Analysis…
Intravenous Immunoglobulin Market Key Players Analysis - Biotest AG, Octapharma …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Intravenous Immunoglobulin Market Size, Share & Trends Analysis Report By Application (Hypogammaglobulinemia, CIDP, Congenital AIDS), By Distribution Channel (hospital pharmacies, speciality pharmacies), Region, Market Outlook And Industry Analysis 2031"
The global Intravenous Immunoglobulin market is estimated to reach over USD 21.22 billion by 2031, exhibiting a CAGR of 6.60% during the forecast period.
Get Free Access…
Exascale Computing Market Key Players Analysis- Hewlett Packard Enterprise Compa …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Exascale Computing Market - (By Component (Hardware, Software, Services), By Deployment (On-premises, Cloud-based), By Customer Type (Government & Defense, Healthcare & Biosciences, Financial Services, Research & Academia, Manufacturing & Energy, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031."
According to the latest research by InsightAce Analytic, the Global Exascale Computing Market is valued at…
Plasma Fractionation Market Robust Expansion is expected to 2031
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Plasma Fractionation Market- (By Product (Immune-Globulins(Intravenous Immune-Globulins, Subcutaneous Immune-Globulins, Other Immune-Globulins), Coagulation Factor Concentrates (Factor VIII, Factor IX, Von Willebrand Factor, Prothrombin Complex Concentrate, Fibrinogen Concentrates, Factor XIII, Others), Albumin, Protease Inhibitors, Other Plasma Products), By Application (Neurology, Immunology, Hematology, Critical Care, Pulmonology, Hemato-Oncology, Rheumatology, Others), By End-User (Hospitals & Clinics, Clinical Research Laboratories, Academic Institutes)),…
More Releases for Model
Animal Model Market
The Global Animal Model Market, detailed in the TechSci Research report titled, "Animal Model Market - Global Industry Size, Share, Trends, Competition Forecast & Opportunities, 2028," exhibited a value of USD 1.67 billion in 2022, poised to grow at a Compound Annual Growth Rate (CAGR) of 7.64% from 2024 to 2028. This comprehensive analysis delves into the intricate web of factors driving the market, including the global burden of chronic…
Executing a Business Model Transformation with A Business Model Canvas
Business model transformation is the process of changing the way a company operates, with the aim of improving its overall performance. This transformation often involves significant changes to a company's existing business model. To ensure that the transformation process is successful, companies can use a tool called the business model canvas. Get a free business model canvas here: https://digitalleadership.com/unite-articles/extended-business-model-canvas/
Steps in Executing a Business Model Transformation with A Business Model Canvas
Business…
Fourth Party Logistics Market : Industry Innovator Model, Solution Integrator Mo …
The fourth party logistics market was valued at $57.9 billion in 2021, and is estimated to reach $111.7 billion by 2031, growing at a CAGR of 6.7% from 2022 to 2031.
Fourth party logistics, popularly known as 4PL, is the model of outsourcing of logistics operations, where the service provider integrates with the company's supply chain department. This logistics partner is responsible for assessing, designing, building, running, and measuring integrated supply…
How Drizly Works: Business Model & Revenue Model
‘Slow and steady wins the race.’
Such is the case with the world’s leading alcohol marketplace, Drizly which carved a unique, step-by-step growth strategy for itself and eventually, succeeded in transforming the way alcohol is bought and sold across various continents. Co-founded in 2012 by Cory Rellas and Nick Rellas, the Boston-based start-up which was one of the first few on-demand liquor delivery apps to make its way into the market,…
Animal Model Market trends, Animal Model Market growth, Animal Model Market size …
Key Findings of Animal Model Market
Developing Regions to Overpower Developed Ones With Regard to Demand
The Asian territory is on the verge of evolving as the next big destination for animal models. This growth can be attributed to various factors such as American and European pharmaceutical companies diversifying their research activities to curtail extra expenses and save costs. Although U.S and Europe have retained their legacy in the global market, their…
Cloud Computing in Healthcare Market By Deployment Model (Public- cloud deployme …
Industry Outlook and Trend Analysis
The Cloud Computing in Healthcare Market was worth USD 3.05 billion in 2014 and is expected to reach approximately USD 16.25 billion by 2023, while registering itself at a compound annual growth rate (CAGR) of 20.43% during the forecast period. Cloud computing, commonly alluded to as 'the cloud', is a technique to access and store the information and projects over the internet. The cloud computing is…
